Literature DB >> 2675860

Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome.

R F Butterworth1.   

Abstract

Chronic alcoholism results in thiamine deficiency as a consequence of inadequate dietary intake and of impaired absorption of the vitamin. In addition, there is evidence to suggest that alcohol reduces thiamine phosphorylation to thiamine pyrophosphate (TPP) in brain. TPP is a cofactor for the pyruvate dehydrogenase complex (PDHC), alpha-ketoglutarate dehydrogenase (alpha KGDH) and transketolase (TK), three enzymes involved in cerebral glucose and energy metabolism. Pyrithiamine-induced thiamine deficiency in the rat results in early, selective, reversible reductions of alpha KGDH in brain; PDHC activities are unaffected. Reductions of alpha KGDH are accompanied by decreased aspartate, glutamate and GABA and by concomitantly increased alanine in the brain of thiamine-deficient animals. It is suggested that decreased alpha KGDH, rather than decreased PDHC constitutes 'the biochemical lesion' in thiamine deficiency encephalopathy first enunciated by Peters in the 1930s. If sufficiently prolonged and severe, thiamine deficiency results in brain cell death. Possible mechanisms involved include compromised cerebral energy metabolism and focal accumulation of lactate, both of which could result from decreased activities of alpha KGDH. In addition, it is proposed that brain cell death in severe thiamine deficiency may result from excessive release of excitotoxic amino acids. Comparable mechanisms could be involved in the cell death and in the pathogenesis of the thiamine-unresponsive symptoms of the Wernicke-Korsakoff Syndrome in humans.

Entities:  

Mesh:

Year:  1989        PMID: 2675860     DOI: 10.1093/oxfordjournals.alcalc.a044913

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  26 in total

Review 1.  Metabolic and structural role of thiamine in nervous tissues.

Authors:  Abdoulaye Bâ
Journal:  Cell Mol Neurobiol       Date:  2008-07-19       Impact factor: 5.046

2.  Can megadoses of thiamine prevent ethanol-induced damages of rat hippocampal CA1 pyramidal neurones?

Authors:  S Wenisch; T Steinmetz; B Fortmann; R Leiser; I Bitsch
Journal:  Z Ernahrungswiss       Date:  1996-09

Review 3.  Genetic studies of alcohol dependence in the context of the addiction cycle.

Authors:  Matthew T Reilly; Antonio Noronha; David Goldman; George F Koob
Journal:  Neuropharmacology       Date:  2017-01-22       Impact factor: 5.250

4.  Role of HIF-1α in the hypoxia inducible expression of the thiamine transporter, SLC19A3.

Authors:  Kristy Zera; Rebecca Sweet; Jason Zastre
Journal:  Gene       Date:  2016-10-12       Impact factor: 3.688

5.  Vascular changes in acute Wernicke's encephalopathy.

Authors:  R Okeda; K Taki; R Ikari; N Funata
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  A quantitative autoradiographic study of muscarinic cholinergic receptor subtypes in the brains of pyrithiamine-treated rats.

Authors:  V L Rao; D D Mousseau; R F Butterworth
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

Review 7.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 8.  Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakoff syndrome.

Authors:  P R Martin; B A McCool; C K Singleton
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 9.  Pathogenesis of diencephalic lesions in an experimental model of Wernicke's encephalopathy.

Authors:  P J Langlais
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

10.  High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism.

Authors:  A Viola; F Nicoli; B Denis; S Confort-Gouny; Y Le Fur; J-P Ranjeva; P Viout; P J Cozzone
Journal:  MAGMA       Date:  2004-08-31       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.